| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/07/2008 | US7431943 Controlled release and taste masking oral pharmaceutical compositions |
| 10/07/2008 | US7431942 Orally disintegrable tablets |
| 10/07/2008 | US7431941 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 10/07/2008 | US7431940 Methods for treatment of human skin damaged by laser treatment or chemical peelings and compositions useful in such methods |
| 10/07/2008 | US7431938 Self invertible inverse latex and powder; easy to employ in solid formulations and in fatty and/or aqueous phases |
| 10/07/2008 | US7431922 Bioadhesive directed somatic cell therapy |
| 10/07/2008 | US7431921 Interferon beta-like molecules |
| 10/07/2008 | US7431916 Simultaneous inhalation delivery of at least two drugs with high efficiency to targeted airways and/or lungs |
| 10/07/2008 | US7431863 Mixture with particulate metaboric acid which is classified as a packing Group III Division 5.1 oxidizer; sanitizing amount of free available chlorine; swimming pools; tablets |
| 10/07/2008 | US7431709 Glaucoma implant device |
| 10/07/2008 | CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 10/07/2008 | CA2427567C Transcutaneous delivery means |
| 10/07/2008 | CA2419147C Fill liquid composition for ibuprofen capsule and capsule preparation |
| 10/07/2008 | CA2399464C Drug delivery apparatus |
| 10/07/2008 | CA2375714C Delayed total release two pulse gastrointestinal drug delivery system |
| 10/07/2008 | CA2366841C Tolperisone-containing pharmaceutical preparation for oral administration |
| 10/07/2008 | CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances |
| 10/07/2008 | CA2359494C Polymer compositions for intraluminal stent |
| 10/07/2008 | CA2350815C Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 10/07/2008 | CA2338646C Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| 10/07/2008 | CA2321523C Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 10/07/2008 | CA2286644C Drug delivery via therapeutic hydrogels |
| 10/07/2008 | CA2264287C A process for producing solid dosage forms |
| 10/07/2008 | CA2259532C Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 10/07/2008 | CA2257077C Treatment of diarrhea |
| 10/07/2008 | CA2251353C Transdermal delivery device for azapirone compounds |
| 10/07/2008 | CA2250219C Materials and methods for making improved liposome compositions |
| 10/07/2008 | CA2197866C Medical contact adhesive |
| 10/07/2008 | CA2127317C Method of producing sustained-release preparation |
| 10/02/2008 | WO2008119033A1 Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family |
| 10/02/2008 | WO2008118754A2 Gamma radiation sterilized nanoparticulate docetaxel compositions and methods for making the same |
| 10/02/2008 | WO2008118712A1 Coacervation process |
| 10/02/2008 | WO2008118552A1 Use of ranolazine for the treatment of cardiovascular diseases |
| 10/02/2008 | WO2008118331A2 Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 10/02/2008 | WO2008118096A1 Carriers for drug delivery |
| 10/02/2008 | WO2008118031A1 Pharmaceutical composition comprising candesartan cilexetil and method for manufacturing thereof |
| 10/02/2008 | WO2008117927A1 Composition and microsphere for controlled-release of exendin, and method of preparing the same |
| 10/02/2008 | WO2008117828A1 Prompt nucleic acid delivery carrier composition |
| 10/02/2008 | WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery |
| 10/02/2008 | WO2008117746A1 Solid fibrinogen preparation |
| 10/02/2008 | WO2008117707A1 Ground crystal of olmesartan medoxomil |
| 10/02/2008 | WO2008117682A1 Non-animal derived soft capsule shell and soft capsule having the same |
| 10/02/2008 | WO2008117313A1 Polymer particles based vaccine |
| 10/02/2008 | WO2008117268A2 A drug delivery device for providing local analgesia, local anesthesia or nerve blockade |
| 10/02/2008 | WO2008117154A2 Stable pharmaceutical compositions, preferably tablets, of hmg-coa reductase inhibitor and process for preparation thereof |
| 10/02/2008 | WO2008117125A2 Compositions capable of facilitating penetration across a biological barrier |
| 10/02/2008 | WO2008117018A2 A tablet having improved stability with at least two actives |
| 10/02/2008 | WO2008116925A1 Topical dermal delivery device for nitric oxide delivery |
| 10/02/2008 | WO2008116806A1 Use of a masked or coated copper salt for the treatment of macular degeneration |
| 10/02/2008 | WO2008116636A2 Therapeutic plaster for trigger and acupuncture points and for meridian therapy |
| 10/02/2008 | WO2008116614A1 Mucosal bioadhesive slow release carrier for delivering active principles |
| 10/02/2008 | WO2008116601A2 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof |
| 10/02/2008 | WO2008116497A1 Topical termal delivery device for nitric oxide delivery |
| 10/02/2008 | WO2008097953A3 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 10/02/2008 | WO2008097897A3 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1) |
| 10/02/2008 | WO2008097539A3 Multi-modal absorption, medicine-delivery lozenge, and use thereof |
| 10/02/2008 | WO2008082948A3 Ophthalmic alginate composition related methods of manufacture and methods of use |
| 10/02/2008 | WO2008073282A3 Ph sensitive matrix formulation |
| 10/02/2008 | WO2008072954A3 Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof |
| 10/02/2008 | WO2008070402A3 Intraocular drug delivery systems |
| 10/02/2008 | WO2008070009A3 Treating solid tumors and monocytic leukemia using topoisomerase inhibitors in liposomes |
| 10/02/2008 | WO2008066778A3 Decontaminant edible product, methods of production and uses thereof |
| 10/02/2008 | WO2008058272A3 Polymer-based antimicrobial agents, methods of making said agents, and products and applications using said agents |
| 10/02/2008 | WO2008057867A3 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 10/02/2008 | WO2008057464A3 Compositions and methods for improving the bioavailability of liothyronine |
| 10/02/2008 | WO2008056139A3 Transdermal therapy |
| 10/02/2008 | WO2008055049A3 Enzyme inhibition using nanoparticles |
| 10/02/2008 | WO2008054412A8 Method and apparatus for forming chromonic nanoparticles |
| 10/02/2008 | WO2008053253A3 Inhaler devices and bespoke pharmaceutical compositions |
| 10/02/2008 | WO2008053192A3 Methods of producing microparticles |
| 10/02/2008 | WO2008033031B1 Mri trackable drug delivery particles, uses and methods thereof |
| 10/02/2008 | WO2008030524A3 Liquid pharmaceutical formulations for oral administration of a cgrp antagonist |
| 10/02/2008 | WO2008005479A3 Charge reversible polymers |
| 10/02/2008 | WO2008002420A3 Antimicrobial hand towel for touchless automatic dispensers |
| 10/02/2008 | WO2007146068A3 Controlled release alfuzosin hydrochloride formulation |
| 10/02/2008 | WO2007144175A3 Pharmaceutical composition comprising hydrochlorothiazide and telmisartan |
| 10/02/2008 | WO2007127158A3 Modification of percutaneous absorption of topically active materials |
| 10/02/2008 | WO2007117648A3 Lubricious coatings for pharmaceutical applications |
| 10/02/2008 | WO2007112285A3 Process for the preparation of a hot-melt extruded laminate |
| 10/02/2008 | WO2007106768A3 Processes and apparatuses for the production of crystalline organic microparticle compositions by micro-milling and crystallization on micro-seed and their use |
| 10/02/2008 | WO2007101400A8 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process |
| 10/02/2008 | US20080242840 Saposin B specific monoclonal antibody for use in treatment and prevention of cell proliferative disorders |
| 10/02/2008 | US20080242820 nanostructure polymeric particles produced by expanding a mixture of propellants, monomers and template selected from proteins and nucleic acids, through nozzles or appertures, and releasing the propellant from mixture in the form of a gas; composite particles used for targeted drug delivery or optics |
| 10/02/2008 | US20080242732 Administering pharmaceutical orally at dose-delivery rate sufficient to provide clinically effective blood level in portal vein, less than required for blood level in peripheral circulation to provide dose-delivery selective in liver |
| 10/02/2008 | US20080242728 gabapentin tannate to treat central nervous system disorders; used in sustained release applications and to improve certain organoleptic properties such as taste |
| 10/02/2008 | US20080242725 pharmaceutical ingredients susceptible to conversion to alternate polymorph forms are prepared by a process of wet granulation in which the ratios of active, fillers, and granulating liquid are controlled in order to avoid polymorphic interconversions |
| 10/02/2008 | US20080242625 Nucleotide-Cochleate Compositions And Methods Of Use |
| 10/02/2008 | US20080242612 Suspension containing milk fat spheres; therapy for infant weight disease |
| 10/02/2008 | US20080241531 Viral fibers |
| 10/02/2008 | US20080241314 Compositions Of Polyvinylacetate and Vinylacetate-Vinyl Laurate Copolymer |
| 10/02/2008 | US20080241268 Compositions and methods for wt1 specific immunotherapy |
| 10/02/2008 | US20080241267 Aqueous phase of polysaccharide and dextran polymer crosslinked by crystallization or stereocomplextion forming hydrogel; bioactive protein, water; deliver therapeutic or diagnostic proteins by injection or inhalation |
| 10/02/2008 | US20080241266 Physiological pH and ionic strength stable colloids; produced by simultaneous introduction of three liquid streams containing inorganic core particles, functionalized polymer and pH adjusting substance in high shear mixing zone within dispersion medium |
| 10/02/2008 | US20080241265 Pharmaceutical Combinations Containing Lamivudine, Stavudine and Nevirapine |
| 10/02/2008 | US20080241264 System and methods for collective nanorobotics for medical applications |
| 10/02/2008 | US20080241263 Oral and/or Topical Compositions Comprising Prebiotics and Sterols |
| 10/02/2008 | US20080241262 Nanoshells and Discrete Polymer-Coated Nanoshells, Methods For Making and Using Same |
| 10/02/2008 | US20080241261 Tablets utillizing polyvinylpyrrolidone finely dispersed in polyvinyl acetate; high dosage levels; applicable to drugs, nutraceuticals, vitamins, minerals, trace elements |
| 10/02/2008 | US20080241260 Compositions for Enhanced Absorption of Biologically Active Agents |
| 10/02/2008 | US20080241259 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |